In Prelude to Probable Transaction DECN Decides to Infuse its Outre’ Precise, TBG Technology to its GenChoice Test Strip, Now in FDA 510k Review
Company Also Plans 3Q 2019 Filing of Four Patents Covering GenUltimate TBG and GenChoice TBG Systems LOS ANGELES, CA /...